iShares Nasdaq Biotechnology ETF (IBB)
| Assets | $11.03B |
| NAV | $171.77 |
| Expense Ratio | 0.46% |
| PE Ratio | 35.35 |
| Shares Out | 64.20M |
| Dividend (ttm) | $0.28 |
| Dividend Yield | 0.16% |
| Ex-Dividend Date | Jun 10, 2021 |
| 1-Year Return | - |
| Volume | 828,451 |
| Open | 172.94 |
| Previous Close | 172.51 |
| Day's Range | 170.69 - 172.94 |
| 52-Week Low | 128.04 |
| 52-Week High | 177.37 |
| Beta | 0.94 |
| Holdings | 272 |
| Inception Date | Feb 5, 2001 |
About IBB
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Top 10 Holdings
51.01% of assets| Name | Symbol | Weight |
|---|---|---|
| Moderna | MRNA | 10.76% |
| Amgen | AMGN | 6.74% |
| Gilead Sciences | GILD | 6.52% |
| Regeneron Pharmaceuticals | REGN | 4.77% |
| Illumina | ILMN | 4.74% |
| BioNTech SE | BNTX | 4.55% |
| IQVIA Holdings | IQV | 3.55% |
| Vertex Pharmaceuticals | VRTX | 3.53% |
| Biogen | BIIB | 3.26% |
| Mettler-Toledo | MTD | 2.59% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 10, 2021 | $0.023238 | Jun 16, 2021 |
| Mar 25, 2021 | $0.131059 | Mar 31, 2021 |
| Dec 14, 2020 | $0.0655 | Dec 18, 2020 |
| Sep 23, 2020 | $0.063 | Sep 29, 2020 |
| Jun 15, 2020 | $0.127 | Jun 19, 2020 |
| Mar 25, 2020 | $0.0554 | Mar 31, 2020 |
News
Biotech Stocks Have Colds, but They Can Heal
This year hasn't been kind to biotechnology stocks and related exchange traded funds. The headwinds faced by these assets were ratcheted up last week when the Biden administration revealed plans to purs...
7 Best ETFs to Buy to Cover a Broad Spectrum of Opportunities
With so many stocks to choose from, trying to find the right ones can be a brutal task, which is why ETFs are so convenient. The post 7 Best ETFs to Buy to Cover a Broad Spectrum of Opportunities appear...
COVID Biotech ETFs Rise At Fever Pace
ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.
Hopes of Moderna (MRNA) Vaccine Approval Boost Biotech
Biotech ETFs shot higher after the FDA formally approved Pfizer's vaccine. Trade the group's two largest funds with these tactical ideas.
The next breakthroughs in biotech
Ali Urman, Ark Invest genomics analyst, joins Fast Money 'The Next,' to discuss future of biotech.
Why biotech is so popular with the Reddit crowd
Alethia Young, Cantor Fitzgerald, joins Power Lunch to discuss winners and losers in the biotech space. The Reddit crowd makes things much more interesting, she says.
Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win
Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.
IBB Vs. XBI: Which Biotech ETF Has A Better Chart?
The SPDR S&P Biotech ETF (NYSE: XBI) is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has broken out. Resistance is a large group of sellers who are...
Why there is opportunity in biotech and the names to watch
Kevin Mahn, Hennion and Walsh chief investment officer, joins 'The Exchange' to discuss the names he's favoring in the pharma sector. For access to live and exclusive video from CNBC subscribe to CNBC P...
Is Your ETF Using a New Rule Book?
CFRA's ETF star ratings are derived from what is inside the portfolio and how much it costs rather than solely relying on past performance. The value of this approach is particularly notable when an ETF...
4 Top Stock Trades for Wednesday: AAPL, TGT, RIDE, IBB
Apple, Target, Lordstown Motors and the iShares Nasdaq Biotechnology ETF (IBB) were our top stock trades for Wednesday. The post 4 Top Stock Trades for Wednesday: AAPL, TGT, RIDE, IBB appeared first on ...
Final Trades: MPLX, Uber, Biotech & more
The "Halftime Report" traders give their top picks to watch for the second half.
Biogen Could Send Biotech ETFs on a Wild Ride
Biotechnology sector-related exchange traded funds are in for a wild ride as Biogen (NasdaqGS: BIIB) is set to receive a verdict from the Food and Drug Administration on its Alzheimer's drug. Biogen sha...
Why Eaton Vance's Yana Barton likes these 'mispriced' stocks
CNBC's "Power Lunch" team discusses markets and the best stock buys right now with Yana Barton of Eaton Vance.
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines
The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.